News Summary: NVIDIA BlueField-4 powers NVIDIA Inference Context Memory Storage Platform, a new kind of AI-native storage infrastructure designed for gigascale inference, to accelerate and scale agentic AI. The new storage processor platform is built for long-context-processing agentic AI systems with lightning-fast long- and short-term memory. Inference Context Memory Storage Platform extends AI ...
News Summary: NVIDIA BlueField-4 powers NVIDIA Inference Context Memory Storage Platform, a new kind of AI-native storage infrastructure designed for gigascale inference, to accelerate and scale agentic AI. The new storage processor platform is built for long-context-processing agentic AI systems with lightning-fast long- and short-term memory. Inference Context Memory Storage Platform extends AI agents’ long-term memory and enables high-bandwidth sharing of context across clusters of rack-scale AI systems — boosting tokens per seconds and power efficiency by up to 5x. Enabled by NVIDIA Spectrum-X Ethernet, extended context memory for multi-turn AI agents improves responsiveness, increases throughput per GPU and supports efficient scaling of agentic inference. LAS VEGAS, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CES—NVIDIA today announced that the NVIDIA BlueField®-4 data processor, part of the full-stack NVIDIA BlueField platform, powers NVIDIA Inference Context Memory Storage Platform, a new class of AI-native storage infrastructure for the next frontier of AI. As AI models scale to trillions of parameters and multistep reasoning, they generate vast amounts of context data — represented by a key-value (KV) cache, critical for accuracy, user experience and continuity. A KV cache cannot be stored on GPUs long term, as this would create a bottleneck for real-time inference in multi-agent systems. AI-native applications require a new kind of scalable infrastructure to store and share this data. NVIDIA Inference Context Memory Storage Platform provides the infrastructure for context memory by extending GPU memory capacity, enabling high-speed sharing across nodes, boosting tokens per seconds by up to 5x and delivering up to 5x greater power efficiency compared with traditional storage. “AI is revolutionizing the entire computing stack — and now, storage,” said Jensen Huang, founder and CEO of NVIDIA. “AI is no longer about one-shot chatbots but intelligent collaborators that u...
Financial markets have quickly gotten used to President Donald Trump’s unorthodox approach to military operations around the globe. Rather than showing unease after Washington’s incursion in Venezuela over the weekend, globally equities hit new highs on Monday, as did gauges for Asia and emerging markets . The gains in stocks echoed advances on the days after US attacks last year on Iraq, Yemen, I...
Financial markets have quickly gotten used to President Donald Trump’s unorthodox approach to military operations around the globe. Rather than showing unease after Washington’s incursion in Venezuela over the weekend, globally equities hit new highs on Monday, as did gauges for Asia and emerging markets . The gains in stocks echoed advances on the days after US attacks last year on Iraq, Yemen, Iran and Syria. While the long-term implications may take years to unfold, there were few signs of investor angst in the aftermath of the Venezuela intervention. Treasury gains reflected lackluster US data, while precious metals extended momentum from last year. The dollar ended lower, while the Mexican and Colombian pesos pared initial declines. Monday’s moves are a sign investors have quickly adapted to Trump’s departure from the rules-based order that has defined global politics since the Second World War. Instead of knee-jerk panic, global equities are being boosted by optimism over artificial intelligence and the prospect they will enhance earnings growth. At the same time, the Federal Reserve is expected to keep cutting interest rates as inflation slows. “Equities typically fade geopolitical headlines when there’s no immediate hit to global demand, supply chains, or financial conditions,” said Charu Chanana , chief investment strategist at Saxo Markets in Singapore. “Investors have also learned that single events often create volatility spikes, but not necessarily lasting earnings downgrades, unless escalation broadens or policy spillovers emerge.” The US on Saturday launched a military operation in Venezuela that captured President Nicolás Maduro and seized control of the country’s governance. Trump said the US would run the country until a leadership transition could be organized. The US incursion may end up being positive for corporate earnings if it helps to stabilize the long-term global oil supply. Crude prices initially fell Monday as the prospect of unlocking t...
Key Points An analyst's recommendation upgrade had a major impact on investor sentiment. It's now a buy, according to the pundit. 10 stocks we like better than Shattuck Labs › A recommendation upgrade from an analyst at the beginning of December set the tone for Shattuck Labs (NASDAQ: STTK) stock in 2025's final month. The clinical-stage biotech's share price rose by almost 74% as a result. Good f...
Key Points An analyst's recommendation upgrade had a major impact on investor sentiment. It's now a buy, according to the pundit. 10 stocks we like better than Shattuck Labs › A recommendation upgrade from an analyst at the beginning of December set the tone for Shattuck Labs (NASDAQ: STTK) stock in 2025's final month. The clinical-stage biotech's share price rose by almost 74% as a result. Good for what ails you The person responsible for that influential move was H.C. Wainwright's Joseph Pantginis, who on Dec. 1 shifted his recommendation on Shattuck to buy from his previous neutral. He set his new price target at $6 per share, which at the time was nearly three times the stock's level. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » According to reports, Pantginis's new take on Shattuck revolves around SL-325, an investigational drug being developed by the healthcare company. The medication is a first-in-class antagonist antibody that targets inflammatory and immune-mediated disorders, and is currently being evaluated in the treatment of irritable bowel syndrome (IBS). The analyst wrote in his update that SL-325 has the potential to be efficacious for multiple indications, not just IBS. Additionally, he wrote that he was encouraged by the company's overall pipeline program. Early stage trial underway In December, Shattuck had considerable momentum behind SL-325. In August, the U.S. Food and Drug Administration (FDA) cleared its Investigational New Drug (IND) application for the treatment, and the first participants in a Phase 1 trial were dosed around that time. Also in August, management disclosed that it had closed a private funding round, which raised as much as $103 million in fresh capital. It stated that this should help fund its operations through 2029. Since financing is a major concern of clinical-stage biotechs (as they are typically...
商務部：決定加強兩用物項對日本出口管制 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】商務部禁止所有兩用物項對日本軍事用途出口。 商務部指，為維護國家安全和利益，履行防擴散等國際義務，決定加強兩用物項對日本出口管...
商務部：決定加強兩用物項對日本出口管制 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】商務部禁止所有兩用物項對日本軍事用途出口。 商務部指，為維護國家安全和利益，履行防擴散等國際義務，決定加強兩用物項對日本出口管制，禁止所有兩用物項對日本軍事用戶、軍事用途，以及有助於提升日本軍事實力的其他最終用戶用途出口。
AMD's latest ROCm updates introduce support for the new Ryzen APUs, while also showcasing the advancements in local AI capabilities. AMD's ROCm Advancements Indicate That Local AI Deployment Is Getting a Lot More Powerful The ROCm software stack has undergone significant evolution over the past few years, with AMD paying special attention to optimizing the ecosystem for edge AI deployment. At CES ...
AMD's latest ROCm updates introduce support for the new Ryzen APUs, while also showcasing the advancements in local AI capabilities. AMD's ROCm Advancements Indicate That Local AI Deployment Is Getting a Lot More Powerful The ROCm software stack has undergone significant evolution over the past few years, with AMD paying special attention to optimizing the ecosystem for edge AI deployment. At CES 2026, the company announced the newest ROCm 7.2.7 version, with a major addition being the inclusion of support for the newly unveiled Ryzen AI 400 'Gorgon Point' APUs. AMD has also made upgrades to the quality of local model deployment, which we'll discuss later. AMD has paid special attention to optimizing ROCm with ComfyUI, the image generation software suite, and claims to have achieved five times higher performance with ROCm 7, compared to previous versions. More importantly, Team Red has paid special attention to improving the ROCm experience with consumer products, which is why Ryzen and Radeon support have doubled in the last year. This indicates that the company targets the software stack's integration with its consumer strategy, a notable approach. Building on the availability of ROCm for a broader user base, AMD has announced seamless integration with the ONNX path for inference and training, targeting Windows AI users and OEMs. Similarly, ROCm is now supported with PyTorch on Windows, as well as TheRock Software Package, an open-source build platform for HIP and ROCm. Windows is shaping up to be a first-class platform for AMD's ROCm, which is why integration is growing significantly, as AMD envisions a world where local AI becomes mainstream. 2 of 9 AMD has also demonstrated why local AI inference on consumer-grade hardware is now approaching cloud-level model quality, as the company compares open-source models like GPT-OSS at Ryzen AI MAX+ APUs with those hosted in the cloud. AMD claims that the performance parity when you target parameters like GPQA Diamond an...